Camilo Garcia

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

Géraldine Gebhart, Laetitia E. Lamberts, Zéna Wimana et al. · Annals of Oncology · 2015 · 341 citations · Full text

Breast Oncology, Oncology, Engineering +13

Tumor Texture Analysis in ¹⁸F-FDG PET: Relationships Between Texture Parameters, Histogram Indices, Standardized Uptake Values, Metabolic Volumes, and Total Lesion Glycolysis

Fanny Orlhac, Michaël Soussan, Jacques-Antoine Maisonobe et al. · Journal of Nuclear Medicine · 2014 · 338 citations · Full text

¹⁸F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO

Géraldine Gebhart, Cristina Gámez‐Cenzano, Eileen Holmes et al. · Journal of Nuclear Medicine · 2013 · 157 citations · Full text

A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease

Robert E. Coleman, Anne-Kirsti Aksnes, Bjørn Naume et al. · Breast Cancer Research and Treatment · 2014 · 97 citations · Full text

Radium-223 Injections, Type 1, Breast Oncology +12

Paget bone disease demonstrated on 68Ga-PSMA ligand PET/CT

Carlos Artigas, J. Alexiou, Camilo Garcia et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 95 citations

Bone Disease, Bone Imaging, Paget Bone Disease +3